MDPI and ACS Style
Chauhan, A.; Prieur, A.; Kolesar, J.; Arnold, S.; Payen, L.; Mahi, Y.; Vire, B.; Sands, M.; Evers, B.M.; Joubert, D.;
et al. hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors. Cancers 2022, 14, 863.
https://doi.org/10.3390/cancers14040863
AMA Style
Chauhan A, Prieur A, Kolesar J, Arnold S, Payen L, Mahi Y, Vire B, Sands M, Evers BM, Joubert D,
et al. hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors. Cancers. 2022; 14(4):863.
https://doi.org/10.3390/cancers14040863
Chicago/Turabian Style
Chauhan, Aman, Alexandre Prieur, Jill Kolesar, Susanne Arnold, Léa Payen, Younes Mahi, Berengere Vire, Madison Sands, B. Mark Evers, Dominique Joubert,
and et al. 2022. "hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors" Cancers 14, no. 4: 863.
https://doi.org/10.3390/cancers14040863